sar
coronaviru
sarscov
highli
pathogen
respiratori
viru
emerg
china
winter
infect
peopl
global
result
death
greatli
increas
mortal
rate
person
year
age
initi
isol
sarscov
infect
patient
identifi
novel
group
coronaviru
genet
mechan
govern
increas
pathogen
viru
remain
undefin
sever
case
sarscov
infect
rapidli
progress
acut
respiratori
distress
syndrom
ard
acut
phase
infect
organ
phase
diffus
alveolar
damag
follow
viru
clearanc
two
clinic
devast
end
stage
lung
diseas
molecular
mechan
govern
sever
end
stage
lung
diseas
outcom
unknown
although
similar
patholog
report
follow
influenza
viru
infect
innat
immun
respons
key
first
line
defens
invad
pathogen
depend
variou
signal
pathway
sensor
ultim
induc
hundr
antivir
protein
establish
suboptim
environ
replic
spread
invad
pathogen
viru
infect
type
interferon
ifn
induct
signal
machineri
key
initi
respons
ifn
induc
either
infect
cell
dendrit
cell
activ
antivir
state
neighbor
cell
signal
viral
infect
way
surprisingli
viru
infect
mous
hepat
viru
influenza
viru
rsv
alphavirus
flavivirus
etc
rodent
lack
type
type
ii
ifn
regulatori
network
result
increas
pathogenesi
mortal
document
key
role
ifn
play
regul
diseas
outcom
given
import
ifn
system
regul
viru
growth
mani
highli
pathogen
virus
encod
protein
antagon
compon
innat
immun
system
ebola
viru
encod
block
signal
influenza
block
activ
v
protein
nipah
hendra
virus
induc
degrad
sever
ifn
antagonist
gene
encod
sarscov
genom
target
ifn
sens
signal
nfkb
induct
howev
role
ifn
regul
sarscov
pathogenesi
vivo
less
clear
microarray
studi
use
rna
pbmc
sar
patient
cameron
et
al
observ
robust
type
ifn
respons
earli
diseas
predict
essenti
viral
clearanc
clinic
recoveri
addit
strong
ifn
respons
gene
typic
induc
ifn
also
upregul
patient
earli
time
sarscov
diseas
interestingli
cameron
colleagu
suggest
ifn
respons
serv
protect
recov
sar
patient
could
becom
dysregul
cytokin
storm
sever
case
contribut
increas
diseas
suboptim
adapt
immun
respons
innat
immun
respons
sarscov
also
chang
age
host
month
old
balbc
mice
respond
sarscov
exacerb
faster
innat
immun
induct
week
old
mice
potenti
explain
increas
suscept
lung
patholog
follow
infect
sever
studi
demonstr
import
innat
respons
viral
clearanc
respiratori
syncyti
viru
rsv
sarscov
requir
produc
effect
immun
respons
control
sever
infect
lung
mx
gene
product
play
import
role
suscept
rodent
influenza
viru
infect
could
regul
sever
sarscov
diseas
vivo
well
glass
et
al
demonstr
sarscov
clear
lung
wildtyp
mice
strain
lack
b
nk
cell
similar
kinet
suggest
innat
immun
respons
alon
suffici
viral
clearanc
hogan
et
al
also
demonstr
key
modul
ifn
signal
requir
resolut
wildtyp
sarscov
infect
indic
import
innat
respons
clearanc
sarscov
paper
compar
pathogenesi
epidem
viru
urbani
isogen
highli
pathogen
mouseadapt
sarscov
differ
mous
strain
defici
differ
innat
immun
signal
compon
specif
test
role
type
type
ii
type
iii
ifn
protect
sarscov
infect
found
absenc
ifn
receptor
alon
instanc
togeth
limit
impact
pathogen
clearanc
nonleth
lethal
strain
sarscov
mice
howev
defici
mice
show
increas
suscept
prolong
viru
shed
mortal
follow
infect
either
viru
importantli
anim
develop
organ
phase
dad
similar
lesion
note
sever
late
stage
human
case
sar
data
reveal
new
mechanist
pathway
regul
sever
viral
pathogenesi
lung
show
sarscov
pathogenesi
depend
independ
type
ii
iii
ifn
signal
provid
evid
consist
essenti
role
control
sarscov
replic
cell
prolifer
wound
repair
progress
sever
organ
phase
dad
lethal
diseas
understand
role
type
type
ii
ifn
respons
sarscov
infect
infect
ifn
receptor
mice
either
late
phase
sarscov
urbani
viru
recombin
isogen
mouseadapt
viru
contain
six
virul
modifi
mutat
anticip
mouseadapt
viru
may
display
promin
pathogen
urbani
viru
urbani
viru
equival
recombin
icsar
virus
lethal
old
balbc
wt
mice
typic
replic
lung
peak
titer
day
postinfect
dpi
clear
next
day
without
clinic
diseas
mortal
contrast
viru
lethal
old
balbc
mice
caus
greater
weight
loss
day
postinfect
death
day
postinfect
infect
wt
type
ifn
receptor
knockout
mice
type
iii
doubl
ifn
receptor
knockout
mice
urbani
viru
figur
wt
viru
figur
wt
mice
clinic
find
includ
weight
loss
data
morbid
ident
infect
wt
mice
infect
viru
lost
weight
day
steadili
recov
next
day
figur
contrast
urbani
viru
infect
mice
continu
gain
weight
cours
infect
figur
case
viru
titer
lung
peak
day
postinfect
approach
titer
pfu
urbani
respect
rapidli
clear
day
postinfect
although
viru
titer
higher
mice
titer
wt
mice
day
postinfect
found
mice
show
increas
suscept
pathogenesi
histolog
outcom
urbani
viru
infect
examin
import
cooper
ifn
pathway
diseas
ifn
receptor
doubl
knockout
mice
infect
urbani
viru
increas
viru
titer
weight
loss
seen
compar
wt
mice
singl
ifn
receptor
knockout
mice
figur
data
suggest
neither
type
type
ii
ifn
receptor
critic
regul
sarscov
infect
pathogen
outcom
mice
contrast
result
ifn
receptor
knockout
mice
previou
studi
suggest
mice
clear
urbani
viru
day
postinfect
infect
mice
evalu
whether
absenc
downstream
ifn
signal
protein
result
increas
suscept
sarscov
infect
determin
cours
infect
patholog
chang
associ
virul
mouseadapt
viru
importantli
mice
infect
viru
suscept
diseas
wt
mice
follow
viru
infect
mice
lost
start
weight
day
continu
lose
weight
day
postinfect
figur
weight
loss
approach
mice
moribund
succumb
lethal
infect
stark
contrast
conson
earlier
report
mice
infect
urbani
viru
initi
gain
weight
wt
mice
day
postinfect
figur
howev
next
day
display
worsen
clinic
diseas
lost
signific
bodi
weight
recov
day
postinfect
die
lung
viru
titer
mice
also
higher
timepoint
test
compar
titer
seen
ifn
receptor
knockout
wt
mice
figur
infect
viru
mice
show
higher
peak
viru
titer
lung
day
pfug
remain
high
pfug
day
postinfect
wt
mice
clear
viru
day
urbani
viru
infect
mice
also
show
increas
sustain
viru
replic
lung
late
day
postinfect
viru
detect
day
postinfect
wt
mice
figur
taken
togeth
data
suggest
ifn
type
ii
receptorindepend
pathway
play
key
role
regul
viral
clearanc
surviv
follow
sarscov
infect
lung
variou
mous
strain
infect
sarscov
analyz
sever
histopatholog
figur
wt
mice
viru
caus
denud
bronchiol
day
postinfect
signific
apoptosi
airway
epitheli
cell
note
multilob
nuclei
condens
chromatin
nuclear
bleb
accumul
apoptot
debri
within
airway
perivascular
cuf
caus
predomin
lymphocyt
similar
lesion
note
balbc
mice
viru
infect
primarili
local
airway
epithelium
day
postinfect
figur
dissemin
area
lung
respiratori
tract
perivascular
cuf
note
vasculatur
day
postinfect
well
day
denud
bronchiol
obstruct
conduct
airway
apoptot
debri
apoptosi
airway
epithelium
rare
observ
although
perivascular
cuf
mix
inflammatori
respons
lymphocyt
infiltr
eosinophil
neutrophil
macrophag
promin
day
postinfect
remain
inflamm
caus
viru
infect
primarili
found
peribronchiolar
area
figur
histolog
chang
lung
mice
similar
wt
mice
inflamm
found
lung
section
tempor
relat
viral
titer
day
postinfect
denud
bronchiol
character
signific
apoptosi
cell
death
airway
epithelium
observ
conduct
airway
obstruct
apoptot
debri
mix
infiltr
compos
lymphocyt
neutrophil
eosinophil
seen
surround
bronchial
epithelium
day
postinfect
signific
inflamm
evid
throughout
lung
alveoli
result
mild
moder
pneumon
note
lung
wt
mice
inflamm
clear
day
postinfect
minim
inflammatori
infiltr
remain
peripheri
lung
minor
peribronchi
lymphocyt
remain
day
postinfect
viru
lung
lesion
mice
indistinguish
seen
wt
infect
anim
day
postinfect
lung
lesion
sever
mice
consist
persist
high
viru
titer
figur
two
featur
notabl
first
extent
inflamm
sever
mice
much
greater
number
macrophag
infiltr
area
lung
find
seen
mous
strain
second
thicken
alveolar
septa
seen
throughout
lung
perivascular
peribronchi
thicken
day
postinfect
inflamm
continu
increas
mice
lung
inflamm
subsid
wt
infect
mice
mice
inflamm
pervas
throughout
lung
dens
pack
infiltr
cell
especi
promin
throughout
peripheri
tissu
macrophag
continu
infiltr
major
resid
alveolar
interstitium
interestingli
larg
foci
contain
dens
pack
fibroblast
macrophag
lymphocyt
seen
throughout
lung
scatter
atyp
larg
cell
found
throughout
foci
focal
mix
inflammatori
infiltr
found
extens
fibrin
deposit
pleuriti
signifi
breakdown
pleura
seen
sampl
well
patholog
consist
prolif
organ
phase
diffus
alveolar
damag
dad
noteworthi
similar
patholog
lesion
seen
mani
fatal
sar
case
lesion
develop
day
wt
mice
inocul
urbani
viru
similar
seen
wt
mice
day
diffus
bronchial
bronchiolar
necrosi
migrat
leukocyt
tcell
neutrophil
eosinophil
vessel
wall
peribronchiolar
perivascular
area
extens
lesion
alveoli
promin
figur
viral
antigen
seen
within
bronchial
bronchiolar
epithelium
data
shown
previous
publish
day
less
necrosi
seen
bronchiolar
epithelium
peribronchiolar
perivascular
cuf
remain
day
necrosi
observ
minor
perivascular
cuf
present
day
lung
mostli
normal
except
minor
perivascular
peribronchiolar
cuf
lymphocyt
mice
infect
urbani
viru
similar
distribut
bronchial
bronchiolar
lesion
lung
seen
wt
mice
day
necrosi
inflamm
edema
observ
around
peribronchiolar
blood
vessel
larger
inflammatori
cell
infiltr
contain
mani
lymphocyt
neutrophil
eosinophil
macrophag
abund
viral
antigen
seen
bronchiolar
epithelium
data
shown
day
bronchiolar
epithelium
foci
regener
littl
necrosi
peribronchiolar
perivascular
inflamm
less
sever
day
plug
cellular
debri
fibrin
fill
bronchiol
blue
ting
note
perivascular
edema
fluid
suggest
earli
collagen
deposit
viral
antigen
much
less
common
epithelium
abund
cellular
debri
airway
day
inflammatori
cell
increas
around
residu
inflammatori
lesion
abund
neutrophil
macrophag
lesion
mark
epitheli
hyperplasia
also
seen
foci
bronchiol
obliteran
seen
airway
interstiti
lesion
develop
around
airway
lesion
one
extend
pleura
produc
focal
pleuriti
much
lung
parenchyma
howev
histolog
normal
cell
cell
debri
seen
express
viral
antigen
day
fibrin
pleuriti
pyogranulomat
lesion
develop
mice
focal
resolv
parenchym
lesion
includ
foci
chronic
interstiti
pneumonia
lung
parenchyma
remain
fairli
normal
day
fibrin
periton
figur
pleuriti
pyogranulomat
lesion
spleen
liver
omentum
develop
major
lesion
like
contribut
ill
death
mice
figur
lesion
character
central
area
necrosi
numer
neutrophil
outer
zone
macrophag
viral
antigen
found
macrophag
pyogranulomat
lesion
figur
e
plasma
cell
becam
abund
splenic
lesion
day
figur
abund
fibrosi
detect
masson
trichrom
stain
seen
splenic
liver
lesion
day
figur
lung
mice
day
mostli
normal
area
residu
chronic
inflamm
pyogranuloma
contain
viral
antigen
pleura
nodul
pyogranulomat
fibrin
inflamm
determin
local
viru
infect
lung
cours
infect
situ
hybrid
use
riboprob
complementari
sarscov
nucleocapsid
rna
label
radioact
nucleotid
visual
viral
rna
tissu
situ
hybrid
perform
lung
wt
mice
harvest
day
postinfect
strain
mice
probe
signal
predominantli
local
airway
epitheli
cell
day
postinfect
figur
correl
patholog
lesion
airway
epitheli
cell
day
postinfect
day
postinfect
viral
rna
virtual
elimin
control
mice
slightli
lesser
extent
mice
occasion
cell
viral
rna
note
peripheri
consist
low
titer
viru
anim
day
day
viral
rna
signal
found
lung
wt
mice
correspond
lack
viral
replic
time
point
contrast
lung
mice
show
signific
viral
rna
signal
throughout
lung
includ
promin
distribut
peripheri
lung
earli
late
time
postinfect
surprisingli
consist
find
histopatholog
viral
rna
signal
lost
airway
epitheli
cell
bronchiol
day
mice
found
throughout
peripheri
lung
promin
focus
larg
focal
compact
cell
foci
correspond
promin
focal
lesion
note
h
e
stain
section
lung
predominantli
compos
fibroblast
macrophag
lymphocyt
figur
interestingli
cellular
debri
seen
foci
may
repres
lyse
airway
epitheli
cell
observ
mark
differ
patholog
lung
wt
mice
compar
mice
infect
viru
investig
whether
affect
inflammatori
infiltr
isol
leukocyt
enzymat
disrupt
mous
lung
harvest
day
postinfect
use
cell
surfac
marker
quantifi
macrophag
neutrophil
eosinophil
popul
wt
mice
greater
differ
leukocyt
number
found
wt
infect
mice
tabl
shown
tabl
eosinophil
popul
increas
wt
mice
mice
neutrophil
increas
wt
mice
mice
addit
number
macrophag
mice
doubl
detect
wt
mice
number
concord
histolog
find
h
e
stain
day
postinfect
use
real
time
rtpcr
cba
analysi
quantifi
chang
mrna
protein
express
level
sever
innat
immun
factor
involv
pulmonari
inflamm
specif
compar
induct
sever
proinflammatori
cytokin
chang
express
infect
analyz
lung
homogen
cba
figur
b
c
quantit
rtpcr
measur
level
mrna
urbani
viru
viru
infect
mice
respect
figur
f
g
h
urbani
viru
infect
lung
minim
chang
seen
wt
mice
cytokin
figur
b
c
howev
mice
signific
increas
protein
express
pattern
detect
across
differ
time
point
peak
day
postinfect
protein
level
increas
steadili
day
day
postinfect
protein
level
peak
day
reduc
level
seen
mock
infect
anim
protein
level
increas
day
diminish
day
postinfect
cytokin
induct
follow
viru
infect
compar
urbani
viru
infect
figur
compar
cytokin
transcript
level
day
postinfect
note
similar
import
differ
follow
viru
infect
wt
mice
show
induct
transcript
day
postinfect
follow
progress
reduc
level
express
return
baselin
day
mice
show
similar
kinet
wt
mice
infect
mice
result
continu
rise
express
till
day
contrast
mice
low
baselin
level
express
day
high
level
express
note
day
correspond
peak
time
inflamm
lung
prior
death
gene
express
level
similar
virusinfect
wt
ifngrmic
transcript
level
induc
day
decreas
day
infect
mice
show
similar
trend
increas
transcript
level
day
express
level
continu
increas
day
postinfect
final
express
show
similar
kinet
viru
infect
wt
control
mice
peak
day
decreas
baselin
level
day
mice
show
similar
kinet
lower
express
level
day
compar
induct
mice
follow
differ
pattern
high
level
express
day
postinfect
persist
high
level
express
day
analyz
realtim
pcr
lung
rna
isol
timecours
wt
mice
figur
show
peek
induct
strain
reduct
throughout
timecous
except
show
either
sustain
late
burst
express
mice
interestingli
show
minim
induct
fold
wt
mice
even
less
mice
thu
signific
differ
cytokin
express
pattern
note
wt
ifnar
defici
anim
typic
wt
mice
express
patter
mice
typifi
perceiv
loss
regulatori
control
persist
high
level
express
mediat
type
iii
ifn
ifn
l
lambda
signal
addit
type
ii
ifn
signal
ifnl
minim
significantli
upregul
infect
wt
mice
day
post
infect
decreas
cours
day
post
infect
figur
receptor
ifnl
heterodim
mice
gener
balbc
mous
background
wt
mous
background
thu
although
direct
comparison
mous
strain
possibl
experi
sarscov
mice
still
inform
background
urbani
viru
caus
diseas
weight
loss
viru
replic
lung
balbc
mice
viru
reach
peak
titer
day
postinfect
infect
resolv
day
contrast
viru
infect
balbc
mice
caus
death
day
postinfect
hypothes
ifnl
import
protect
sarscov
infect
viru
would
virul
mice
lack
ifnl
receptor
ifnl
receptor
knockout
mice
would
show
evid
diseas
normal
balbc
mice
would
viru
infect
mice
may
result
enhanc
patholog
weight
loss
higher
viru
titer
increas
lung
patholog
hypothesi
test
inocul
control
balbc
mice
mice
urbani
viru
viru
pb
weight
loss
either
balbc
mice
infect
urbani
viru
data
shown
thu
lack
signal
potenti
clinic
diseas
lung
urbani
viru
infect
balbc
mice
harvest
day
postinfect
found
differ
titer
viru
lung
balbc
mice
figur
lung
infect
mice
analyz
h
e
stain
urbani
viru
infect
mice
produc
mild
inflamm
peak
day
resolv
day
postinfect
replic
pattern
seen
balbc
mice
figur
viru
infect
caus
weight
loss
andor
death
day
postinfect
balbc
similar
find
mice
data
shown
lost
weight
day
postinfect
lung
harvest
day
postinfect
differ
viru
titer
observ
figur
mous
strain
show
peak
viru
titer
day
log
decreas
day
lung
patholog
analyz
h
e
stain
balbc
mice
show
similar
high
level
inflamm
day
postinfect
remark
similar
patholog
outcom
figur
taken
togeth
found
role
protect
infect
either
urbani
strain
sarscov
balbc
wt
mice
respond
differ
viru
infect
lethal
balbc
mice
caus
transient
weight
loss
mice
analyz
effect
knock
type
iii
ifn
signal
pathway
treat
mice
background
neutral
antibodi
receptor
use
mice
inject
antibodi
day
day
postinfect
describ
literatur
found
differ
weight
loss
pathogenesi
mice
compar
mice
inject
pb
figur
mice
show
weight
loss
day
postinfect
recov
day
end
start
weight
lung
analyz
day
postinfect
show
differ
patholog
compar
mice
data
shown
group
mice
show
epitheli
cell
denud
day
postinfect
repair
clearanc
day
viru
titer
slightli
increas
pb
inject
mice
differ
statist
signific
suggest
inhibit
type
type
iii
signal
mice
increas
pathogenesi
viru
neither
protect
mice
diseas
sarscov
infect
human
rapidli
progress
atyp
pneumonia
acut
phase
diffus
alveolar
damag
ard
first
day
acut
lung
injuri
mani
patient
follow
develop
organ
phase
dad
viru
clearanc
patholog
associ
sever
clinic
outcom
death
especi
promin
elderli
molecular
mechan
virushost
signal
network
regul
progress
end
stage
lung
diseas
unknown
consider
import
given
global
diseas
burden
associ
previou
studi
laboratori
demonstr
age
mice
infect
recombin
virus
encod
glycoprotein
earli
phase
zoonot
sarscov
strain
develop
ard
character
hyalin
membran
dad
report
show
defici
mice
especi
prone
develop
organ
phase
dad
innat
immun
system
play
central
role
regul
earli
host
respons
viru
infect
promot
adapt
immun
respons
type
ii
iii
ifn
typic
produc
differ
cell
popul
use
distinct
membran
bound
receptor
gain
entri
cell
type
use
type
ii
use
ifngr
type
iii
use
howev
three
share
common
cytoplasm
signal
protein
call
transloc
nucleu
induc
express
multipl
overlap
ifn
regul
gene
isg
delet
signal
compon
involv
signal
pathway
diminish
innat
immun
respons
pathogen
increas
suscept
sever
bacteri
viral
agent
mice
lack
ifn
receptor
show
increas
suscept
west
nile
influenza
ebola
friend
viru
rsv
polioviru
review
moreov
phenotyp
note
mice
demonstr
key
role
entir
innat
immun
pathway
regul
diseas
sever
viral
titer
patholog
stark
contrast
demonstr
paradox
find
sarscov
urbani
virus
induc
sever
end
stage
lung
diseas
depend
mechan
independ
ifn
receptor
type
ii
iii
signal
data
point
novel
mechan
function
regul
diseas
sever
lung
follow
sarscov
induc
acut
lung
injuri
contrast
exist
paradigm
sarscov
infect
success
control
clear
ifnlr
defici
mice
delet
lead
increas
viru
replic
morbid
mortal
follow
infect
either
human
epidem
strain
sarscov
urbani
mous
adapt
strain
result
suggest
novel
mechan
regul
sever
end
stage
lung
diseas
follow
sarscov
infect
independ
role
ifn
signal
isg
express
although
possibl
cooper
combin
sever
ifn
signal
requir
regul
sarscov
infect
feel
possibl
exist
role
control
cell
prolifer
wound
heal
may
base
caus
increas
diseas
seen
mice
nevertheless
develop
tripl
knockout
affect
ifn
receptor
would
address
mechanist
possibl
function
key
gatekeep
mediat
signal
nucleu
induc
overlap
distinct
isg
less
well
appreci
viral
pathogenesi
studi
also
play
key
role
cell
cycl
arrest
cell
prolifer
thu
defect
may
augment
viral
lung
diseas
sever
potenti
mechan
shown
import
control
tumor
format
sever
type
cancer
includ
lung
colon
pancreat
brain
cancer
role
cell
prolifer
studi
context
pulmonari
fibrosi
mous
fibroblast
show
increas
prolifer
expos
growth
factor
compar
wt
mous
fibroblast
addit
mice
demonstr
greater
suscept
chemic
induc
pulmonari
fibrosi
via
bleomycin
treatment
data
suggest
outsid
innat
immun
respons
may
function
key
regul
cell
prolifer
wound
heal
respons
data
also
suggest
may
regul
wound
heal
respons
follow
acut
lung
injuri
associ
viral
infect
similar
cell
cycl
regul
seen
model
diseas
lung
mice
infect
viru
progress
earli
stage
pulmonari
fibrosislik
diseas
day
acut
lung
injuri
ali
seen
lung
approxim
damag
seen
ard
often
seen
sever
case
sar
human
especi
elderli
found
perivascular
cuf
collaps
alveolar
parenchyma
invas
amplif
macrophag
neutrophil
eosinophil
fibroblast
importantli
extens
fibrin
deposit
throughout
lung
patholog
find
mirror
seen
ali
pulmonari
fibrosi
ard
sarscov
like
mani
highli
pathogen
virus
express
sever
protein
antagon
ifn
sens
amplif
network
sarscov
block
nuclear
import
plp
block
activ
n
shown
ifn
antagonist
well
importantli
antagonist
function
context
sarscov
infect
within
discret
permiss
cell
suggest
infect
cell
multipl
pathway
inhibit
ifn
signal
may
creat
essenti
environ
may
contribut
patholog
seen
diseas
describ
influenza
like
cytokin
storm
significantli
contribut
increas
pathogen
outcom
target
noninfect
cell
loss
cell
knockout
mous
may
contribut
describ
loss
wound
heal
control
induct
fibrosi
lead
develop
lethal
diseas
state
sarscov
infect
molecular
mechan
govern
sarscov
pathogenesi
recent
begun
evalu
use
mice
target
genet
defect
challeng
viru
sheahan
et
al
identifi
role
adapt
protein
tlr
signal
necessari
antibodi
product
protect
infect
diseas
mice
show
enhanc
suscept
viru
infect
mice
mice
show
increas
morbid
mortal
viru
infect
viral
replic
lung
detect
day
postinfect
data
suggest
intric
balanc
innat
adapt
immun
respons
necessari
protect
sarscov
infect
current
work
understand
two
process
interact
host
use
proteom
microarray
analys
cameron
et
al
show
individu
surviv
sarscov
infect
control
innat
immun
isg
cytokin
respons
individu
progress
sever
diseas
demonstr
uncontrol
innat
immun
respons
high
level
isg
immunoglobulin
express
increas
cytokin
respons
poor
antibodi
respons
spike
protein
caus
lack
regul
understood
infect
epidem
urbani
mous
adapt
strain
sarscov
caus
increas
patholog
mice
thu
seem
like
mous
adapt
mutat
enhanc
intrins
pathogen
properti
sarscov
produc
sever
end
stage
lung
diseas
mice
howev
sarscov
urbani
spread
respiratori
tract
spleen
liver
mice
suggest
although
damag
may
induc
viral
infect
patholog
result
host
respons
infect
though
clear
whether
repres
normal
pattern
spread
whether
mutat
evolv
viru
promot
spread
distribut
organ
similar
find
seen
autopsi
sampl
individu
die
sar
airway
intact
regener
acut
case
show
spread
outer
pulmonari
parenchyma
similar
mice
infect
sarscov
elderli
individu
infect
sarscov
epidem
intrigu
recent
work
shown
cell
age
host
signal
cascad
less
respons
stimuli
signal
age
macrophag
hyporespons
observ
studi
express
increas
substanti
mice
hypothes
may
respons
lack
neg
feedback
via
signal
pathway
sar
epidem
age
individu
cohort
sever
diseas
highest
mortal
rate
propos
alter
signal
age
individu
may
lead
increas
suscept
sever
diseas
rule
possibl
type
ifn
receptor
redund
sarscov
mediat
diseas
delet
type
receptor
observ
increas
pathogenesi
proof
must
await
avail
mous
strain
contain
delet
three
receptor
howev
find
type
patholog
produc
mice
wt
sarscov
demonstr
role
noninn
immun
process
resembl
produc
sever
infect
sarscov
patient
propos
new
potenti
pathway
regul
end
stage
lung
diseas
follow
viral
infect
hypothes
increas
suscept
mice
result
differ
role
cell
first
loss
result
defici
ifn
respons
result
higher
titer
viru
lung
secondli
loss
allow
unregul
cell
prolifer
respons
innat
immun
respons
caus
enhanc
damag
lung
death
anim
find
also
point
increas
role
cell
damag
respons
viral
infect
potenti
target
therapi
highli
pathogen
respiratori
infect
mice
studi
treat
follow
iacuc
guidelin
infect
mice
pretreat
ketamin
xylazin
anesthet
mice
euthan
weight
drop
start
weight
clinic
symptom
warrant
per
iacuc
approv
anim
hous
care
experiment
protocol
accord
uncchapel
hill
institut
anim
care
use
committe
guidelin
nih
guidelin
depend
experi
perform
vero
cell
grown
mem
invitrogen
carlsbad
ca
supplement
fcii
hyclon
south
logan
ut
gentamicinkanamycin
gibcobrl
stock
biolog
sarscov
urbani
recombin
sarscov
icsar
mouseadapt
sarscov
propag
titer
vero
vero
cell
cryopreserv
use
describ
experi
infecti
viru
perform
class
ii
biolog
safeti
cabinet
certifi
biosafeti
level
laboratori
contain
redund
exhaust
fan
personnel
wear
protect
equip
includ
tyvek
suit
hood
hepafilt
power
airpurifi
respir
papr
describ
wildtyp
mice
catalog
number
obtain
tacon
farm
germantown
ny
mous
adapt
sarscov
infect
type
ifn
receptor
defici
ifn
alphabeta
receptor
mice
bred
unc
mous
facil
chapel
hill
north
carolina
type
ii
ifn
receptor
defici
ifn
gamma
receptor
mice
stock
number
purchas
jackson
laboratori
bar
harbor
urbani
viru
infect
mice
obtain
gift
dr
joan
durbin
ohio
state
univers
ifn
alphabetagamma
receptor
doubl
knockout
mice
bred
nih
anim
facil
bethesda
md
ifnlambda
receptor
knockout
mice
zymogen
seattl
washington
bred
unc
chapel
hill
anim
facil
anim
hous
care
experiment
protocol
accord
uncchapel
hill
institut
anim
care
use
committe
guidelin
nih
guidelin
depend
experi
perform
anim
studi
conduct
anim
biosafeti
level
laboratori
use
sealsaf
hepafilt
cage
personnel
wore
person
protect
equip
includ
tyvek
suit
hood
posit
pressur
hepafilt
air
respir
week
old
mice
anesthet
mixtur
ketaminexylazin
isofluran
intranas
infect
either
pb
alon
recombin
biolog
epidem
viru
icsar
urbani
pb
invitrogen
carlsbad
ca
mice
monitor
h
interv
virusinduc
morbid
mortal
subset
mice
euthan
day
postinfect
dpi
character
infect
less
pathogen
urbani
viru
infect
anim
sampl
day
postinfect
tissu
analyz
histopatholog
chang
viral
titer
quantifi
amount
infecti
viru
tissu
infect
organ
weigh
place
ml
dpb
homogen
titer
via
plaqu
assay
vero
cell
previous
describ
urbani
infect
supernat
wv
lung
homogen
prepar
titrat
vero
cell
monolay
plate
previous
describ
viru
titer
express
per
g
tissu
lower
limit
detect
lung
tissu
fix
paraformaldehyd
ph
embed
paraffin
section
prepar
unc
histopatholog
core
facil
determin
extent
inflamm
section
stain
hematoxylin
eosin
h
e
score
blind
manner
supernat
weightvolum
lung
homogen
use
detect
cytokin
chemokin
use
bd
cba
kit
bd
bioscienc
accord
manufactur
instruct
lower
limit
detect
protein
includ
kit
protocol
riboprob
specif
n
gene
sarscov
urbani
gene
epsteinbarr
viru
neg
control
probe
gener
maxiscript
vitro
transcript
kit
ambion
situ
hybrid
perform
describ
previous
briefli
deparaffin
tissu
section
hybrid
riboprob
overnight
tissu
wash
dehydr
grade
ethanol
coat
ntb
autoradiographi
emuls
kodak
incub
day
follow
develop
section
counterstain
hematoxylin
silver
grain
deposit
analyz
light
microscopi
signal
determin
compar
silver
grain
deposit
parallel
section
hybrid
riboprob
complementari
gene
epsteinbarr
viru
lung
mock
sarscov
infect
mice
remov
homogen
directli
ml
trizol
reagent
invitrogen
total
rna
isol
follow
manufactur
instruct
complementari
cdna
gener
total
rna
use
ng
random
primer
invitrogen
superscript
ii
revers
transcriptas
invitrogen
realtim
pcr
experi
perform
use
taqman
gene
express
assay
abi
prism
appli
biosystem
rrna
use
endogen
control
use
normal
assay
rel
fold
induct
amplifi
mrna
detect
use
ct
method
taqman
primer
set
use
appli
biosystem
appli
biosystem
tnfa
appli
biosystem
appli
biosystem
ifnb
appli
biosystem
appli
biosystem
appli
biosystem
appli
biosystem
appli
biosystem
mice
inocul
describ
sacrif
exsanguin
day
postinfect
lung
perfus
via
cardiac
punctur
pb
lung
dissect
minc
incub
hr
vigor
shake
digest
buffer
rpmi
fb
mm
hepe
mgml
collagenas
roch
mgml
dnase
sigma
cell
pass
micron
cell
strainer
resuspend
rpmi
media
layer
ml
lympholytem
cedarlan
centrifug
min
rpm
cell
collect
wash
wash
buffer
hbss
mm
hepe
total
viabl
cell
determin
trypan
blue
exclus
isol
cell
incub
antimous
bd
pharmingen
min
ice
stain
fac
stain
buffer
hbss
fb
normal
rabbit
serum
follow
antibodi
ebiosci
cell
fix
overnight
paraformaldehyd
analyz
cyan
cytomet
dako
use
summit
softwar
percent
start
weight
viral
titer
inflammatori
cell
number
evalu
statist
signific
differ
nonparametr
mannwhitney
test
within
graphpad
prism
unpair
ttest
use
graphpad
softwar
p
valu
consid
signific
